Glaucoma
📧 Sign up to get email alerts when something new happens for Glaucoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 study evaluating the efficacy and safety of OPC-1085EL ophthalmic solution in glaucoma or ocular hypertension completed with results…
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: SENSIMED Triggerfish in Closed Eyes [Phase 4]
A Phase 4 clinical trial update indicates completion of the SENSIMED Triggerfish study for glaucoma.
-
FDA approval · 2015-11-10FDA Approved: BRINZOLAMIDE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for brinzolamide submitted by Sandoz Inc under NDA 020816, reflecting an approved modification t…
-
FDA approval · 2015-11-05FDA Approved: IOPIDINE 1% — Supplemental Application (Harrow Eye, LLC)
The FDA approved a supplemental application to market IOPIDINE 1% (apraclonidine hydrochloride ophthalmic solution) under Harrow Eye, LLC. T…
-
FDA approval · 2015-11-05FDA Approved: SIMBRINZA — Supplemental Application (Alcon Laboratories, Inc.)
FDA approved a supplemental application for SIMBRINZA (brinzolamide/brimonidine tartrate) submitted by Alcon Laboratories, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: Intraocular Pressure and Tolerability Study of Preservative-free Prostaglandins (Bimatoprost and Latanoprost) on Glaucoma and Ocular Hypertension: European, Multicentric, Investigator-led, Single Masked Study [Phase 4]
A Phase 4, European multicenter, investigator-led trial comparing preservative-free bimatoprost and latanoprost on intraocular pressure and …
-
FDA approval · 2015-10-15FDA Approved: COMBIGAN — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for COMBIGAN (brimonidine tartrate, timolol maleate) submitted by Allergan, Inc., updating the produ…
-
CLINICAL_TRIALS research · 2015-10-14Clinical Trial Update: Effects of Marihuana Use on Optic Nerve Parameters and Ocular Blood Flow
This entry provides a clinical trial update on how marijuana use may affect optic nerve measurements and blood flow in the eye, with intraoc…
-
FDA approval · 2015-10-08FDA Approved: TIMOPTIC-XE — Supplemental Application (Bausch & Lomb Incorporated)
FDA approved a supplemental application for TIMOPTIC-XE (timolol maleate) from Bausch & Lomb Incorporated.
-
FDA label_change · 2015-10-06FDA Approved: TIMOLOL MALEATE — Supplemental Application (Pacific Pharma, Inc.)
FDA approved a supplemental application for timolol maleate from Pacific Pharma, Inc. to update the drug’s labeling.
-
FDA approval · 2015-10-06FDA Approved: TIMOLOL MALEATE — Supplemental Application (Pacific Pharma, Inc.)
The FDA approved a supplemental application for Timolol Maleate from Pacific Pharma, Inc., under an approved supplemental submission.
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: A Placebo-Controlled Study of INS117548 Ophthalmic Solution in Subjects With Glaucoma (P08650) [Phase 1]
This update reports the completed Phase 1, placebo-controlled trial of INS117548 ophthalmic solution in subjects with glaucoma.
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma [Phase 3]
Phase 3 study evaluating the safety and efficacy of bimatoprost ophthalmic solution in paediatric patients with glaucoma; the trial was term…
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: Obstructive Sleep Apnea Syndrome in Glaucoma
A clinical trial evaluating obstructive sleep apnea syndrome in glaucoma has been terminated. No results are reported in this update.
-
CLINICAL_TRIALS withdrawal · 2015-09-23Clinical Trial Update: Effect of an Anterior Chamber Infusion System on Trabeculectomy Outcomes [Phase 1]
A Phase 1 clinical trial evaluating an anterior chamber infusion system to improve trabeculectomy outcomes for glaucoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: Timing of Treatment Completion in Staged Selective Laser Trabeculoplasty (SLT): Early vs. Late Completion [Phase 3]
A Phase 3 clinical trial comparing early versus late completion of staged selective laser trabeculoplasty for glaucoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-09-18Clinical Trial Update: SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma [Phase 3]
A Phase 3 randomized trial comparing the SOLX Gold Shunt to a control implant for refractory glaucoma has been suspended.
-
CLINICAL_TRIALS research · 2015-09-18Clinical Trial Update: Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device [NA]
A pilot clinical trial of a new adjustable glaucoma drainage device is sponsored by Rheon Medical SA. The trial status is unknown.
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: The High Cup/Disc Ratio in Children
This clinical trial update reports on the status of a study examining high cup-to-disc ratio in children with glaucoma. The trial status is …
-
CLINICAL_TRIALS trial_result · 2015-09-03Clinical Trial Update: The Effect of Ocular Massage on the Management of Elevated Intraocular Pressure After Acute Angle Closure [NA]
A completed clinical trial evaluated whether ocular massage can help manage elevated intraocular pressure after an acute angle-closure event…
-
CLINICAL_TRIALS trial_result · 2015-08-21Clinical Trial Update: Biomechanical Changes After Trabeculectomy
This clinical trial update describes observed biomechanical changes after trabeculectomy surgery in patients with glaucoma.
-
CLINICAL_TRIALS trial_result · 2015-08-20Clinical Trial Update: Adult Providing Access to the Visual Environment (PAVE) - Glaucoma Pilot [NA]
The adult PAVE glaucoma pilot trial has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-18Clinical Trial Update: Additive Intra-ocular Pressure Reduction Effect of Fixed Combination of Maleate Timolol 0.5%/Dorzolamide 2% on Monotherapy With Latanoprost in Patients With Elevated Intra-ocular Pressure [Phase 4]
A Phase 4 study evaluating whether the fixed combination timolol maleate 0.5% / dorzolamide 2% provides additional intraocular pressure redu…
-
FDA label_change · 2015-08-14FDA Approved: TIMOPTIC IN OCUDOSE — Supplemental Application (Bausch & Lomb Incorporated)
FDA approved a supplemental application for TIMOPTIC IN OCUDOSE (timolol maleate) from Bausch & Lomb Incorporated.
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: Pupillary Response After Glaucoma Medication [NA]
A completed clinical trial evaluating pupillary response after glaucoma medications, sponsored by Glostrup University Hospital in Copenhagen…